Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Adenoid Cystic × Cetuximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 144 Squamous Cell Carcinoma of Head and Neck 83 Head and Neck Neoplasms 81 Colonic Neoplasms 40 Rectal Neoplasms 34 Neoplasm Metastasis 31 Carcinoma, Non-Small-Cell Lung 24 Carcinoma, Squamous Cell 22 Esophageal Neoplasms 17 Pancreatic Neoplasms 16 Neoplasms 16 Lung Neoplasms 14 Stomach Neoplasms 13 Recurrence 11 Laryngeal Neoplasms 11 Esophageal Squamous Cell Carcinoma 11 Mouth Neoplasms 10 Colorectal Cancer Metastatic 10 Oropharyngeal Neoplasms 9 Carcinoma 8 Breast Neoplasms 8 Adenocarcinoma Of Esophagus 8 Tongue Neoplasms 7 Nasopharyngeal Carcinoma 7 Hypopharyngeal Neoplasms 7 Neoplasms, Squamous Cell 5 Laryngeal Diseases 5 Glioblastoma 5 Uterine Cervical Neoplasms 4 Pharyngeal Neoplasms 4

Interventions

pembrolizumab 3 lenvatinib 2 gallium 68 PSMA-11 2 apatinib 2 Magnetic Resonance Spectroscopy 2 Imatinib Mesylate 2 Cisplatin 2 Carboplatin 2 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2 tislelizumab 1 regorafenib 1 enfortumab vedotin 1 cabozantinib 1 amivantamab 1 Tretinoin 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Radiation 1 Protons 1 Pemetrexed 1 Nivolumab 1 Nelfinavir 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Lutetium-177 1 Lutetium 1 Glutamate Carboxypeptidase II 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01192087 2013-04-24

ACCEPT

Heidelberg University

Phase 1/2 Unknown

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡